Alpha Cognition (ACOG) Finished Goods (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly Finished Goods of $672700.0 for Q4 2025, down 13.09% quarter-over-quarter from $774027.0 in Q3 2025.

Alpha Cognition (ACOG) Finished Goods (2025 - 2026) Analysis & Trends

Alpha Cognition's Finished Goods history runs 1 years deep, the most recent figure standing at $672700.0 for Q4 2025.

In Q4 2025, Finished Goods changed N/A year-over-year to $672700.0; the TTM figure through Dec 2025 stood at $672700.0 (changed N/A YoY), while the FY2025 annual figure was $672700.0, changed N/A from the prior year.
Finished Goods for Q4 2025 stood at $672700.0, down from $774027.0 in the prior quarter.
The five-year high for Finished Goods was $875852.0 in Q2 2025, with the low at $90549.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.59 Bn	131.73 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.21 Bn	78.22 Bn	3.93 Bn
3	Argenx Se	65.65 Bn	60.47 Bn	1.37 Bn
4	Moderna	57.67 Bn	52.53 Bn	52.00 Mn
5	BeOne Medicines	42.10 Bn	37.00 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn
7	BioNTech SE	27.90 Bn	9.51 Bn	668.28 Mn
8	Insmed	27.51 Bn	26.35 Bn	358.27 Mn
9	Royalty Pharma	27.29 Bn	26.45 Bn	-
10	Alpha Cognition	208.05 Mn	166.61 Mn	5.70 Mn

Download Data